BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Seamus Fernandez does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 MBXMBX Biosciences, Inc. Common Stock | Buy | $44.00 | Apr 2025 | +308.8% | Hit |
 ARQTArcutis Biotherapeutics Inc | Buy | — | Apr 2025 | +50.5% | — |
 PCVXVaxcyte Inc | Buy | $160.00 | Mar 2025 | −29.3% | Miss |
| PCVXVaxcyte Inc | Buy | $160.00 | Feb 2025 | −28.0% | Miss |
 MLYSMineralys Therapeutics, Inc. Common Stock | Buy | — | Feb 2025 | +234.1% | — |
| ARQTArcutis Biotherapeutics Inc | Buy | — | Feb 2025 | +113.3% | — |
| ARQTArcutis Biotherapeutics Inc | Buy | — | Feb 2025 | +127.5% | — |
 APGEApogee Therapeutics, Inc. Common Stock | Buy | — | Feb 2025 | +81.7% | — |
| APGEApogee Therapeutics, Inc. Common Stock | Buy | — | Dec 2024 | +62.0% | — |
 TENXTenax Therapeutics Inc | Buy | $16.00 | Oct 2024 | +111.0% | Miss |
| MBXMBX Biosciences, Inc. Common Stock | Buy | $44.00 | Oct 2024 | −27.2% | Miss |
 GSKGlaxoSmithKline PLC ADR | Buy | — | Mar 2024 | −9.9% | — |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.